UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-09-23 6:56 pm Sale |
2021-09-22 | 13G | Taysha Gene Therapies, Inc. TSHA |
UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO | 1,156,255 3.010% |
-1,022,745 (-46.94%) |
Filing |
| 2021-02-16 1:35 pm Purchase |
2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO | 2,179,000 5.770% |
2,179,000 (New Position) |
Filing |
| 2021-02-03 6:14 pm Purchase |
2020-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO | 2,179,000 5.770% |
2,179,000 (New Position) |
Filing |